In addition, ZEB1 can effectively reverse the role of ERβ as a switch in regulating VM, suggesting that it is more likely to be a key factor in the prognosis of RCC, although more relevant studies are needed to confirm this. The gene discussed is ESR2; the disease is renal cell adenocarcinoma.